Cronos Group Inc (CRON)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.24B
Last updated: Nov 17, 2026 at 11:04 AM ET
Cronos Group Inc (CRON) Financials: Revenue, Profit and Cash Flow
Cronos Group reported revenue of $146.59M for the fiscal year ended Dec 31, 2025, up 24.6% from the year before. That year, net income was -$2.93M with a net margin of -2.0%, operating cash flow was $25.87M and free cash flow was $149.00K. The quarter ended Sep 30, 2026 had revenue of $83.90M and net income of $17.83M.
Revenue and Margins
The operating margin was -11.9% in the fiscal year ended Dec 2025, the highest of the 3 years shown with an operating margin. Over the 9 years to Dec 2025, revenue grew from $412.27K, a compound annual rate of 92.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $146.59M | +24.6% | 42.8% | -11.9% | -2.0% |
| Dec 2024 | $117.61M | +34.8% | 21.4% | -65.1% | 34.0% |
| Dec 2023 | $87.24M | +0.6% | 13.7% | -97.2% | -85.5% |
| Dec 2022 | $86.75M | +34.4% | 17.8% | -128.4% | -194.5% |
| Dec 2021 | $64.56M | +18.8% | -27.3% | -452.2% | -615.2% |
| Dec 2020 | $54.35M | +112.0% | -47.5% | -403.6% | -138.5% |
| Dec 2019 | $25.64M | +93.7% | -68.6% | -598.0% | 4546.1% |
| Dec 2018 | $13.23M | +320.5% | 46.9% | -154.5% | -164.9% |
| Dec 2017 | $3.15M | +663.3% | 50.0% | -194.5% | -47.1% |
| Dec 2016 | $412.27K | N/A | 359.7% | -722.6% | -214.8% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income fell 37.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $146.59M | $117.61M | $87.24M | $86.75M | $64.56M | $54.35M | $25.64M | $13.23M | $3.15M | $412.27K |
| Cost of revenue | $83.83M | $92.42M | $75.33M | $71.31M | $82.15M | $80.19M | $43.24M | $7.02M | $1.57M | $550.68K |
| Gross profit | $62.76M | $25.20M | $11.91M | $15.44M | -$17.59M | -$25.83M | -$17.60M | $6.21M | $1.57M | $1.48M |
| Research and development | $4.45M | $4.23M | $5.84M | $13.13M | $21.84M | $20.37M | $12.15M | $1.81M | $0 | $0 |
| Operating income | -$17.39M | -$76.53M | -$84.80M | -$111.43M | -$291.97M | -$219.39M | -$153.32M | -$20.45M | -$6.12M | -$2.98M |
| Net income | -$2.93M | $40.02M | -$74.55M | -$168.73M | -$397.20M | -$75.27M | $1.17B | -$21.82M | -$1.48M | -$885.55K |
| EBITDA | N/A | -$8.46M | N/A | N/A | -$115.86M | -$84.92M | $1.13B | -$18.50M | -$1.61M | -$466.59K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $83.90M | $53.01M | $45.21M | $32.04M | $48.83M | $33.45M | $32.26M | $30.30M | $34.26M | $27.76M | $25.29M | $23.91M |
| Gross profit | $32.28M | $28.45M | $19.15M | $16.19M | $18.33M | $14.50M | $13.73M | $10.81M | $3.61M | $6.30M | $4.48M | $1.91M |
| Operating income | $9.03M | $7.40M | -$1.83M | -$7.50M | -$503.00K | -$5.32M | -$4.07M | -$11.37M | -$33.66M | -$15.56M | -$15.95M | -$21.64M |
| Net income | $17.83M | $35.66M | $15.71M | -$491.00K | $28.32M | -$38.48M | $7.72M | $43.94M | $7.32M | -$8.76M | -$2.48M | -$45.03M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $337.00K by $791.46M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.20B | $1.17B | $1.14B | $1.21B | $1.40B | $1.93B | $2.09B | $183.47M | $80.29M | $31.92M |
| Current assets | $944.09M | $936.11M | $933.31M | $960.16M | $1.08B | $1.37B | $1.57B | $39.94M | $18.01M | $6.02M |
| Cash and equivalents | $791.79M | $858.80M | $669.29M | $764.64M | $886.97M | $1.08B | $1.20B | $23.93M | $7.32M | $2.58M |
| Total liabilities | $54.18M | $55.33M | $44.14M | $72.05M | $63.46M | $217.51M | $341.41M | $34.92M | $11.65M | $6.86M |
| Short-term debt | $337.00K | $1.02M | $994.00K | $1.33M | $2.71M | $1.32M | $320.70K | $30.00K | $0 | $2.98M |
| Shareholder equity | $1.09B | $1.06B | $1.10B | $1.14B | $1.34B | $1.71B | $1.75B | $148.45M | $68.64M | $25.06M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.20B | $1.18B | $1.17B | $1.20B | $1.18B | $1.18B | $1.15B | $1.17B | $1.18B | $1.09B | $1.11B | $1.14B |
| Total liabilities | $73.40M | $62.41M | $48.30M | $54.18M | $46.36M | $45.02M | $39.06M | $55.33M | $52.82M | $35.26M | $35.76M | $44.14M |
| Cash and equivalents | $411.19M | $467.02M | $821.86M | $791.79M | $784.17M | $794.42M | $797.82M | $858.80M | $862.03M | $848.19M | $855.11M | $669.29M |
| Shareholder equity | $1.07B | $1.07B | $1.07B | $1.09B | $1.08B | $1.08B | $1.07B | $1.06B | $1.08B | $1.06B | $1.08B | $1.10B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 0.6% of operating cash flow. Dividends and share repurchases together came to 10838.9% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $25.87M | $18.84M | -$42.84M | -$88.95M | -$153.62M | -$144.87M | -$131.19M | -$7.52M | -$4.28M | -$4.82M |
| Capital expenditures | $25.72M | $12.41M | $2.50M | $3.45M | $11.14M | $31.41M | $38.66M | $88.31M | $32.93M | $1.13M |
| Free cash flow | $149.00K | $6.43M | -$45.34M | -$92.40M | -$164.76M | -$176.28M | -$169.86M | -$95.83M | -$37.20M | -$5.95M |
| Dividends paid | $6.41M | $0 | $0 | $384.00K | N/A | $1.02M | $0 | $0 | $0 | $0 |
| Share repurchases | $9.74M | $0 | $0 | N/A | N/A | N/A | $3.72M | $7.58M | $2.11M | $120.56K |
| Investing cash flow | -$76.56M | $175.15M | -$59.50M | -$1.84M | -$28.90M | $20.15M | -$603.27M | -$93.91M | -$29.90M | -$5.96M |
| Financing cash flow | -$19.91M | -$1.23M | -$1.03M | -$2.90M | -$13.44M | -$3.05M | $1.86B | $122.11M | $39.07M | $12.52M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $34.34M | $24.01M | $10.90M | $11.84M | $13.31M | $2.82M | -$2.10M | $7.72M | $11.58M | $1.74M | -$2.20M | $16.82M |
| Capital expenditures | $9.95M | $1.74M | $1.88M | $2.14M | $4.48M | $3.84M | $15.26M | $3.54M | $6.42M | $729.00K | $1.72M | $1.22M |
| Free cash flow | $24.39M | $22.27M | $9.02M | $9.70M | $8.83M | -$1.02M | -$17.35M | $4.18M | $5.17M | $1.01M | -$3.93M | $15.60M |
Frequently Asked Questions About CRON
What is Cronos Group's annual revenue?
Cronos Group reported revenue of $146.59M for the fiscal year ended Dec 31, 2025.
How fast is Cronos Group's revenue growing?
Revenue was up 24.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 19.1%.
Is Cronos Group profitable?
No. Cronos Group reported net income of -$2.93M for the fiscal year ended Dec 31, 2025, with a net margin of -2.0%.
How much free cash flow does CRON generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $25.87M minus capital expenditures of $25.72M produced free cash flow of $149.00K.
How much debt does Cronos Group have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $337.00K and cash and equivalents of $791.79M.
CRON pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors